Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Efficacy of an XPO1 inhibitor in combination with irinotecan in a preclinical colorectal cancer model.
Journal: Frontiers in oncology
Published: October 09, 2025
Overcoming doxorubicin resistance in triple-negative breast cancer using the class I-targeting HDAC inhibitor bocodepsin/OKI-179 to promote apoptosis.
Journal: Breast cancer research : BCR
Published: November 08, 2023
Deficiency in PER proteins has no effect on the rate of spontaneous and radiation-induced carcinogenesis.
Journal: Cell cycle (Georgetown, Tex.)
Published: October 05, 2013
Selenium is a modulator of circadian clock that protects mice from the toxicity of a chemotherapeutic drug via upregulation of the core clock protein, BMAL1.
Journal: Oncotarget
Published: January 18, 2012
Showing 1-5 of 5
Last Updated: 09/26/2026